Clinical trial condition

DLBCL

Explore clinical trials studying DLBCL. Study availability and eligibility vary by location and protocol.

51 public trials 20 recruiting studies

Refine in advanced search Browse all conditions

DLBCL trial results

Enrolling by Invitation

Long-term Follow-up of Patients Treated With Genetically Modified Autologous T Cells

NCT03628612

Conditions: ALL, Adult and Pediatric, Blood Protein Disorders, Cardiovascular Diseases, +20 more
Locations: University of Miami Miami, Florida, United States

Washington University in St. Louis St Louis, Missouri, United States

St David's South Austin Medical Center Austin, Texas, United States

Queen Elizabeth University Hospital Glasgow, United Kingdom

View Trial Details

Not Yet Recruiting

Single-Arm Clinical Study of EZH2i in Combination With Glofitamab + GemOx in Patients With Relapsed/ Refractory DLBCL

NCT07643805

Conditions: DLBCL
Locations: The First Affiliated Hospital with Nanjing Medical University Nanjing, Jiangsu, China

View Trial Details

Not Yet Recruiting

A Study of Rocbrutinib Combined With R-GemOx in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma

NCT07570017

Conditions: DLBCL
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China

View Trial Details

Not Yet Recruiting

Gut Microbiome in DLBCL Treated With Glofitamab

NCT07498920

Conditions: DLBCL, Glofitamab, Gut Biome
Locations: Not specified

View Trial Details

Not Yet Recruiting

CD-RCHOP in ND DLBCL With a Combination of TP53 Mutation and Del(17p)

NCT06750991

Conditions: DLBCL
Locations: No. 197 Ruijin 2nd Road, Huangpu District, Shanghai Shanghai, Shanghai Municipality, China

View Trial Details

Not Yet Recruiting

Zanubrutinib Combined With BEAM for ASCT in Relapsed and Refractory DLBCL

NCT06652165

Conditions: DLBCL
Locations: Not specified

View Trial Details

Completed

ACE1831 in Adult Subjects With Relapsed/ Refractory CD20-expressing B-cell Malignancies

NCT05653271

Conditions: B-cell Lymphoma, Burkitt Lymphoma, DLBCL, +23 more
Locations: AdventHealth Orlando Orlando, Florida, United States

Emory University Atlanta, Georgia, United States

Indiana University Simon Comprehensive Cancer Center Indianapolis, Indiana, United States

Norton Cancer Institute Louisville, Kentucky, United States

View all 13 locations

View Trial Details

Completed

Autologous CD22 CAR T Cells in Adults w/ Recurrent or Refractory B Cell Malignancies

NCT04088890

Conditions: B-ALL, B-cell Non Hodgkin Lymphoma, DLBCL, +11 more
Locations: Stanford Medical Center Stanford, California, United States

View Trial Details

Completed

Cardiotoxicity and Other Late Effects After Radiotherapy and Immuno-chemoTherapy in Non-Hodgkin lYmphoma

NCT07041827

Conditions: Cardiomyopathies, Cardiotoxicity, Cardiovascular Diseases, +27 more
Locations: Netherlands Cancer Institute Amsterdam, North Holland, Netherlands

View Trial Details

Completed

89Zr-DFO-REGN3767 in PET Scans in People With Diffuse Large B Cell Lymphoma (DLBCL)

NCT04566978

Conditions: DLBCL, Large B-cell Lymphoma
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

DLBCL

DLBCL trial results

Related conditions